The global conversation surrounding psychedelic-assisted therapy has shifted dramatically. As individuals seek alternative paths for substance use disorders, treatment-resistant depression, and deep-seated trauma, one specific compound stands out for its profound, systemic intervention: ibogaine. Derived from the root bark of the African shrub Tabernanthe iboga, this powerful alkaloid is known for its ability to interrupt […]
The legal landscape surrounding ibogaine continues to evolve rapidly as scientific evidence accumulates and attitudes toward psychedelic medicine shift globally. As we approach 2026, the regulation of this naturally occurring alkaloid varies dramatically across jurisdictions, creating a patchwork of legal frameworks that reflects diverse approaches to balancing therapeutic potential against safety concerns. Understanding where ibogaine […]